Researcher enrolled 139 patients in a randomized control trial. The patients received 2g of either topical or intravenous TXA.
Here are four insights:
1. Calculated blood and Hgb loss were lower in the IV group.
2. Both the IV and topical TXA patient groups effectively reduced the transfusion rate.
3. The use of TXA in THA resulted in savings of $314 per patient.
4. Study authors recommended the use of TXA via IV as it was easier to use.
More articles on orthopedics:
Annual & hourly orthopedic surgeon salary — 10 latest statistics
Sports medicine pioneer Dr. Joseph Gaar passes away at 77: 4 things to know
The Real Football Network selects Dr. David Chao as a contributor — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.